NewAmsterdam Pharma (NAMS) FCF Margin (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported FCF Margin of 1007.96% for Q1 2026, up 21716.0% on a YoY basis from N/an in Q1 2025, and up 99.21% sequentially from 128046.88% in Q4 2025.
NewAmsterdam Pharma (NAMS) FCF Margin (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 4 years of FCF Margin data on file, last reported at 1007.96% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 21716.0% year-over-year to 1007.96%; the trailing twelve-month figure through Mar 2026 stood at 630.12% (down 33158.0% YoY), and the FY2025 full-year result was 657.82%, down 30833.0% from the prior year.
- FCF Margin improved to 1007.96% in Q1 2026, from 128046.88% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 43.2% in Q3 2024 to a low of 128046.88% in Q4 2025.
- A 4-year average of 12719.25% and a median of 1411.35% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 382569 bps in 2024 and slumped 12775339 bps in 2025, its largest moves.
- Tracing NAMS's FCF Margin over 4 years: stood at 4119.18% in 2023, then surged by 93 bps to 293.49% in 2024, then tumbled by 43530 bps to 128046.88% in 2025, then surged by 99 bps to 1007.96% in 2026.
- Business Quant data shows NAMS's FCF Margin at 1007.96% in Q1 2026, 128046.88% in Q4 2025, and 9428.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NewAmsterdam Pharma | 3.72 Bn | 3.72 Bn | - | -1,007.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,007.96% |
| Dec 31, 2025 | -128,046.88% |
| Sep 30, 2025 | -9,428.45% |
| Jun 30, 2025 | -197.23% |
| Mar 31, 2025 | -1,225.12% |
| Dec 31, 2024 | -293.49% |
| Sep 30, 2024 | -43.20% |
| Jun 30, 2024 | -2,377.71% |
| Mar 31, 2024 | -3,924.84% |
| Dec 31, 2023 | -4,119.18% |
| Sep 30, 2023 | -1,597.59% |
| Mar 31, 2023 | -369.34% |